441 related articles for article (PubMed ID: 10344734)
1. Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification.
Toyota M; Ho C; Ahuja N; Jair KW; Li Q; Ohe-Toyota M; Baylin SB; Issa JP
Cancer Res; 1999 May; 59(10):2307-12. PubMed ID: 10344734
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells.
Nguyen C; Liang G; Nguyen TT; Tsao-Wei D; Groshen S; Lübbert M; Zhou JH; Benedict WF; Jones PA
J Natl Cancer Inst; 2001 Oct; 93(19):1465-72. PubMed ID: 11584062
[TBL] [Abstract][Full Text] [Related]
3. [Screening the differentially methylated DNA sequences of colorectal cancer by methylated CpG islands amplification coupled with representational difference analysis].
Zhu YM; Lin J; Huang Q; Lai MD
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Oct; 20(5):425-9. PubMed ID: 14556198
[TBL] [Abstract][Full Text] [Related]
4. CpG island methylator phenotype in colorectal cancer.
Toyota M; Ahuja N; Ohe-Toyota M; Herman JG; Baylin SB; Issa JP
Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8681-6. PubMed ID: 10411935
[TBL] [Abstract][Full Text] [Related]
5. Screening for genomic fragments that are methylated specifically in colorectal carcinoma with a methylated MLH1 promoter.
Koinuma K; Kaneda R; Toyota M; Yamashita Y; Takada S; Choi YL; Wada T; Okada M; Konishi F; Nagai H; Mano H
Carcinogenesis; 2005 Dec; 26(12):2078-85. PubMed ID: 16033773
[TBL] [Abstract][Full Text] [Related]
6. Accelerated age-related CpG island methylation in ulcerative colitis.
Issa JP; Ahuja N; Toyota M; Bronner MP; Brentnall TA
Cancer Res; 2001 May; 61(9):3573-7. PubMed ID: 11325821
[TBL] [Abstract][Full Text] [Related]
7. Screening of significantly hypermethylated genes in breast cancer using microarray-based methylated-CpG island recovery assay and identification of their expression levels.
Lian ZQ; Wang Q; Li WP; Zhang AQ; Wu L
Int J Oncol; 2012 Aug; 41(2):629-38. PubMed ID: 22581028
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of differentially methylated CpG islands in pancreatic carcinoma.
Ueki T; Toyota M; Skinner H; Walter KM; Yeo CJ; Issa JP; Hruban RH; Goggins M
Cancer Res; 2001 Dec; 61(23):8540-6. PubMed ID: 11731440
[TBL] [Abstract][Full Text] [Related]
9. PAX6 methylation and ectopic expression in human tumor cells.
Salem CE; Markl ID; Bender CM; Gonzales FA; Jones PA; Liang G
Int J Cancer; 2000 Jul; 87(2):179-85. PubMed ID: 10861471
[TBL] [Abstract][Full Text] [Related]
10. Roles of cell division and gene transcription in the methylation of CpG islands.
Bender CM; Gonzalgo ML; Gonzales FA; Nguyen CT; Robertson KD; Jones PA
Mol Cell Biol; 1999 Oct; 19(10):6690-8. PubMed ID: 10490608
[TBL] [Abstract][Full Text] [Related]
11. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing.
Gonzalez-Zulueta M; Bender CM; Yang AS; Nguyen T; Beart RW; Van Tornout JM; Jones PA
Cancer Res; 1995 Oct; 55(20):4531-5. PubMed ID: 7553622
[TBL] [Abstract][Full Text] [Related]
12. Identification of differentially methylated sites within unmethylated DNA domains in normal and cancer cells.
Tryndyak V; Kovalchuk O; Pogribny IP
Anal Biochem; 2006 Sep; 356(2):202-7. PubMed ID: 16824473
[TBL] [Abstract][Full Text] [Related]
13. Methylation of the TPEF- and PAX6-promoters is increased in early bladder cancer and in normal mucosa adjacent to pTa tumours.
Hellwinkel OJ; Kedia M; Isbarn H; Budäus L; Friedrich MG
BJU Int; 2008 Mar; 101(6):753-7. PubMed ID: 18070176
[TBL] [Abstract][Full Text] [Related]
14. Correlations of partial and extensive methylation at the p14(ARF) locus with reduced mRNA expression in colorectal cancer cell lines and clinicopathological features in primary tumors.
Zheng S; Chen P; McMillan A; Lafuente A; Lafuente MJ; Ballesta A; Trias M; Wiencke JK
Carcinogenesis; 2000 Nov; 21(11):2057-64. PubMed ID: 11062168
[TBL] [Abstract][Full Text] [Related]
15. High-throughput methylation profiling by MCA coupled to CpG island microarray.
Estécio MR; Yan PS; Ibrahim AE; Tellez CS; Shen L; Huang TH; Issa JP
Genome Res; 2007 Oct; 17(10):1529-36. PubMed ID: 17785535
[TBL] [Abstract][Full Text] [Related]
16. Promoter hypermethylation downregulates RUNX3 gene expression in colorectal cancer cell lines.
Ku JL; Kang SB; Shin YK; Kang HC; Hong SH; Kim IJ; Shin JH; Han IO; Park JG
Oncogene; 2004 Sep; 23(40):6736-42. PubMed ID: 15273736
[TBL] [Abstract][Full Text] [Related]
17. Use of DNA from human stools to detect aberrant CpG island methylation of genes implicated in colorectal cancer.
Belshaw NJ; Elliott GO; Williams EA; Bradburn DM; Mills SJ; Mathers JC; Johnson IT
Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1495-501. PubMed ID: 15342451
[TBL] [Abstract][Full Text] [Related]
18. [Methylation status of p16 gene in colorectal carcinoma and normal colonic mucosa].
Zhang J; Lai M; Chen J
Zhonghua Bing Li Xue Za Zhi; 2000 Apr; 29(2):95-8. PubMed ID: 11866898
[TBL] [Abstract][Full Text] [Related]
19. HOXB13, a target of DNMT3B, is methylated at an upstream CpG island, and functions as a tumor suppressor in primary colorectal tumors.
Ghoshal K; Motiwala T; Claus R; Yan P; Kutay H; Datta J; Majumder S; Bai S; Majumder A; Huang T; Plass C; Jacob ST
PLoS One; 2010 Apr; 5(4):e10338. PubMed ID: 20454457
[TBL] [Abstract][Full Text] [Related]
20. Isolation of CpG islands from large genomic clones.
Cross SH; Clark VH; Bird AP
Nucleic Acids Res; 1999 May; 27(10):2099-107. PubMed ID: 10219082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]